Seo Am Hur1,2, Sabina A Guler1,2, Nasreen Khalil3, Pat G Camp2,4, Jordan A Guenette2,4, Jeffrey J Swigris5, Christopher J Ryerson1,2. 1. 1 Department of Medicine and. 2. 2 Centre for Heart Lung Innovation, University of British Columbia and St. Paul's Hospital, Vancouver, British Columbia, Canada. 3. 3 The Lung Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada. 4. 4 Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada; and. 5. 5 Interstitial Lung Disease Program in the Autoimmune Lung Centre and the Division of Psychosocial Medicine, National Jewish Health, Denver, Colorado.
Abstract
RATIONALE: The optimal method of physical activity measurement has not been determined in patients with fibrotic interstitial lung disease (ILD). OBJECTIVES: To assess the validity, internal consistency, and responsiveness of the International Physical Activity Questionnaire long form (IPAQ-LF) and to estimate the minimal important difference (MID) for moderate to vigorous physical activity (MVPA) in patients with fibrotic ILD. METHODS: This two-center prospective cohort study included a convenience sample of 111 outpatients with fibrotic ILD who wore waist and wrist ActiGraph accelerometers for 7 consecutive days, followed by self-administration of the IPAQ-LF. Both measurements were performed at baseline and 6-month follow-up. Spearman rank correlations were used to evaluate the IPAQ-LF validity in comparison to activity monitor data, lung function, step count, and quality of life. The internal consistency of the IPAQ-LF was determined using Cronbach's α. Self-reported changes in IPAQ-LF parameters were compared among tertiles of change measured by the waist activity monitor to assess the responsiveness of the IPAQ-LF after 6 months. Anchor- and distribution-based methods were used to estimate the MID for MVPA. RESULTS: Self-reported MVPA minutes, activity-related energy expenditure, sedentary time, and inactive time of the IPAQ-LF generally showed moderate to strong correlations with corresponding waist activity monitor data, step count, lung function, and quality of life. The Cronbach's α of the IPAQ-LF was 0.78. The IPAQ-LF was responsive at detecting increases in weekly MVPA and energy expenditure. The MIDs for MVPA were 8 to 26 and 13 to 58 min/wk using the anchor-based method for waist activity monitor and IPAQ-LF data, respectively. The distribution-based MID estimate for MVPA was 104 to 242 min/wk. CONCLUSIONS: The IPAQ-LF has acceptable validity and internal consistency for measuring daily physical activity in patients with fibrotic ILD. The IPAQ-LF was responsive at detecting increases in physical activity but limited in its ability to detect declines or changes in inactivity. Using an anchor-based approach, the MID for MVPA measured by a waist activity monitor is approximately 26 min/wk.
RATIONALE: The optimal method of physical activity measurement has not been determined in patients with fibrotic interstitial lung disease (ILD). OBJECTIVES: To assess the validity, internal consistency, and responsiveness of the International Physical Activity Questionnaire long form (IPAQ-LF) and to estimate the minimal important difference (MID) for moderate to vigorous physical activity (MVPA) in patients with fibrotic ILD. METHODS: This two-center prospective cohort study included a convenience sample of 111 outpatients with fibrotic ILD who wore waist and wrist ActiGraph accelerometers for 7 consecutive days, followed by self-administration of the IPAQ-LF. Both measurements were performed at baseline and 6-month follow-up. Spearman rank correlations were used to evaluate the IPAQ-LF validity in comparison to activity monitor data, lung function, step count, and quality of life. The internal consistency of the IPAQ-LF was determined using Cronbach's α. Self-reported changes in IPAQ-LF parameters were compared among tertiles of change measured by the waist activity monitor to assess the responsiveness of the IPAQ-LF after 6 months. Anchor- and distribution-based methods were used to estimate the MID for MVPA. RESULTS: Self-reported MVPA minutes, activity-related energy expenditure, sedentary time, and inactive time of the IPAQ-LF generally showed moderate to strong correlations with corresponding waist activity monitor data, step count, lung function, and quality of life. The Cronbach's α of the IPAQ-LF was 0.78. The IPAQ-LF was responsive at detecting increases in weekly MVPA and energy expenditure. The MIDs for MVPA were 8 to 26 and 13 to 58 min/wk using the anchor-based method for waist activity monitor and IPAQ-LF data, respectively. The distribution-based MID estimate for MVPA was 104 to 242 min/wk. CONCLUSIONS: The IPAQ-LF has acceptable validity and internal consistency for measuring daily physical activity in patients with fibrotic ILD. The IPAQ-LF was responsive at detecting increases in physical activity but limited in its ability to detect declines or changes in inactivity. Using an anchor-based approach, the MID for MVPA measured by a waist activity monitor is approximately 26 min/wk.
Entities:
Keywords:
accelerometry; exercise; interstitial lung disease; minimal clinically important difference
Authors: Seo Am Hur; Sabina A Guler; Nasreen Khalil; Pat G Camp; Jordan A Guenette; Christopher J Ryerson Journal: Lung Date: 2019-06-01 Impact factor: 2.584
Authors: Maria-Arantzazu Ruescas-Nicolau; María Luz Sánchez-Sánchez; Sara Cortés-Amador; Sofía Pérez-Alenda; Anna Arnal-Gómez; Assumpta Climent-Toledo; Juan J Carrasco Journal: Int J Environ Res Public Health Date: 2021-04-29 Impact factor: 3.390
Authors: Louisa Y Herring; Helen Dallosso; Sally Schreder; Emily J Smith; Ghazala Waheed; Laura J Gray; Kamlesh Khunti; Thomas Yates; Patrick J Highton; Alex V Rowlands; Ian Hudson; Samuel Seidu; Melanie J Davies Journal: Open Heart Date: 2021-02